tiprankstipranks
Advertisement
Advertisement

XLO Stock Latest News

Xilio Therapeutics appoints Ben Harshbarger as chief legal officer
The FlyXilio Therapeutics appoints Ben Harshbarger as chief legal officer
10d ago
XLO
Xilio Therapeutics Adjusts Board Structure Following Shareholder Votes
PremiumCompany Announcements
Xilio Therapeutics Adjusts Board Structure Following Shareholder Votes
27d ago
8K
XLO
Xilio Therapeutics files $250M mixed securities shelf
PremiumThe Fly
Xilio Therapeutics files $250M mixed securities shelf
2M ago
XLO
Xilio announces new preclinical data for XTX601 at AACR
PremiumThe Fly
Xilio announces new preclinical data for XTX601 at AACR
3M ago
XLO
Xilio Therapeutics Announces Board Changes and Committee Leadership
PremiumCompany Announcements
Xilio Therapeutics Announces Board Changes and Committee Leadership
3M ago
8K
XLO
Xilio Therapeutics appoints Blanchard to its Board of Directors
PremiumThe FlyXilio Therapeutics appoints Blanchard to its Board of Directors
3M ago
XLO
Upcoming Stock Splits This Week (March 16–20, 2026) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (March 16–20, 2026) – Stay Invested
4M ago
XLO
CLIR
Xilio Therapeutics Inc trading halted, news pending
Premium
The Fly
Xilio Therapeutics Inc trading halted, news pending
4M ago
XLO
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
PremiumCompany Announcements
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
4M ago
8K
XLO
Xilio Therapeutics announces 1-for-14 reverse stock split
PremiumThe Fly
Xilio Therapeutics announces 1-for-14 reverse stock split
4M ago
XLO
Xilio Therapeutics Updates Investor Presentation on I-O Strategy
PremiumCompany Announcements
Xilio Therapeutics Updates Investor Presentation on I-O Strategy
4M ago
8K
XLO
Xilio Therapeutics announces inducement grants
PremiumThe Fly
Xilio Therapeutics announces inducement grants
4M ago
XLO
XLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsXLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
XLO
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
Premium
Company Announcements
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
4M ago
8K
XLO
Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing
Premium
Company Announcements
Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing
5M ago
8K
XLO
Xilio Therapeutics Announces Leadership Transition and Pipeline Updates
PremiumCompany Announcements
Xilio Therapeutics Announces Leadership Transition and Pipeline Updates
6M ago
8K
XLO
Xilio Therapeutics highlights upcoming milestones, corporate updates
PremiumThe Fly
Xilio Therapeutics highlights upcoming milestones, corporate updates
6M ago
XLO
Xilio Therapeutics Extends Cash Runway Into 2027
PremiumCompany Announcements
Xilio Therapeutics Extends Cash Runway Into 2027
6M ago
8K
XLO
Xilio Therapeutics Approves 2025 Stock Incentive Plan
PremiumCompany Announcements
Xilio Therapeutics Approves 2025 Stock Incentive Plan
8M ago
8K
XLO
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
PremiumCompany AnnouncementsXilio Therapeutics Reports Revenue Growth Amidst Challenges
8M ago
XLO
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
Premium
The Fly
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
8M ago
XLO
Xilio Therapeutics reports Q3 EPS (11c) vs (22c) last year
Premium
The Fly
Xilio Therapeutics reports Q3 EPS (11c) vs (22c) last year
8M ago
XLO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >